Breaking Fasts Ahead of Cardiac Caths
Launched by UNIVERSITY OF SOUTH FLORIDA · May 29, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Breaking Fasts Ahead of Cardiac Caths," is looking to find out if patients need to fast before undergoing a cardiac catheterization, a procedure often used to diagnose or treat heart issues. Researchers want to see if allowing patients to eat and drink before the procedure makes them feel more comfortable without increasing the risk of any complications, such as vomiting or breathing problems. Participants will be randomly placed into two groups: one group will fast for a certain period before the procedure, while the other group can eat and drink normally.
To participate in this trial, individuals should be scheduled for urgent, non-high risk cardiac catheterizations due to worsening chest pain or mild heart attacks. However, those with certain severe health conditions or younger than 18 years old will not be eligible. Before the procedure, participants will fill out short surveys about their comfort and satisfaction, and researchers will keep track of their health for 30 days afterward to ensure safety. This study aims to help improve patient care and comfort during important heart procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All scheduled urgent inpatient non-high risk cardiac catheterizations for worsening angina (cardiac chest pain or anginal equivalent), unstable angina, or non-high risk NSTEMI-NSTEMI's with GRACE score \<140 points) utilizing proceduralist guided sedation
- Exclusion Criteria:
- • High risk NSTEMI's defined as NSTEMI's with a GRACE score \>140 points
- • Hemodynamic instability (\<SBP 90)
- • Unstable arrythmias
- • Chest pain refractory to nitroglycerin drip
- • New ejection fraction less than 25%
- • Evidence of severe decompensated heart failure on presentation requiring BiPAP or mechanical intubation
- • Inability to consent
- • Patients \<18 years old
- • Pregnant patients
- • Need for general anesthesia
- • Acute hypoxic respiratory failure requiring \>6L Nasal Cannula Supplementation, BiPAP, or invasive ventilation
- • Emergent interventions: STEMI/high risk NSTEMI
- • Need for mechanical circulatory support-ECMO, Impella or intra-aortic balloon pump
About University Of South Florida
The University of South Florida (USF) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong commitment to improving patient outcomes, USF leverages its diverse faculty expertise and state-of-the-art facilities to conduct rigorous and ethically sound research. The university fosters collaboration across disciplines, engaging in partnerships that enhance the translation of scientific discoveries into effective therapeutic interventions. USF's clinical trial programs are designed to address pressing health challenges and contribute to the body of knowledge in various medical fields, ultimately aiming to benefit communities and improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tampa, Florida, United States
Patients applied
Trial Officials
Samip Vasaiwala, MD
Principal Investigator
USF Department of Internal Medicine; Division of Cardiovascular Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported